Will Heron Therapeutics Inc (HRTX) Beat the Rest of the Stocks in the Healthcare Sector?

Heron Therapeutics Inc (HRTX) is near the top in its sector according to InvestorsObserver. HRTX gets an overall rating of 73. That means it scores higher than 73% of stocks. Heron Therapeutics Inc gets a 98 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

HRTX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on HRTX!

See Full HRTX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 73 would rank higher than 73 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Heron Therapeutics Inc Stock Today?

Heron Therapeutics Inc (HRTX) stock is down -0.99% while the S&P 500 is up 0.22% as of 12:20 PM on Tuesday, Mar 19. HRTX has fallen -$0.03 from the previous closing price of $2.96 on volume of 921,228 shares. Over the past year the S&P 500 has gained 30.61% while HRTX is up 40.87%. HRTX lost -$0.80 per share the over the last 12 months. Click Here to get the full Stock Report for Heron Therapeutics Inc stock.